EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunohistochemical‐Based Molecular Typing of ACRG Combined With Immune‐Associated PD ‐ L1 Expression Can Predict the Prognosis of Gastric Cancer

Fang Li iD, Huiyan Deng iD, Zeqing Hu, Zihao Chen, Huirui Zhang, Jiankun He, Xiaoxiao Wang, Yueping Liu

Cancer Medicine · 2025

DOI: 10.1002/cam4.70863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Fang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, B7-H1 Antigen, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science Research Project of Hebei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC) is a molecularly heterogeneous disease with diverse clinical outcomes. Traditional classifications lack predictive accuracy, necessitating alternative molecular subtyping approaches for effective prognosis prediction. The Asian Cancer Research Group (ACRG) molecular subtypes, combined with immune‐associated PD‐L1 expression, offer a promising framework to predict patient outcomes and potentially guide treatment strategies in GC.

Methods

This study retrospectively analyzed 1007 primary GC patients who underwent surgical resection between January 2017 and June 2019 at the Fourth Hospital of Hebei Medical University. Comprehensive immunohistochemical and fluorescent PCR‐capillary electrophoresis analyses were conducted to determine ACRG molecular subtypes (microsatellite instability [MSI], microsatellite stability with epithelial–mesenchymal transition [MSS/EMT], MSS/TP53 + , and MSS/TP53 − ) and PD‐L1 expression. We assessed the relationship between these classifications and various clinicopathological parameters, including survival outcomes, using Cox regression and Kaplan–Meier analysis.

Results

The ACRG subtypes showed significant associations with clinicopathological features, including tumor invasion depth, Lauren classification, and HER2 status. The MSI subtype (6.7% of cases) was associated with higher PD‐L1 positivity and a favorable prognosis, whereas the EMT subtype had the lowest 5‐year survival rate (34.55%) and was predominantly linked to diffuse‐type histology. PD‐L1 positivity correlated with worse survival outcomes, with independent predictive value alongside ACRG subtypes (HR for PD‐L1 = 1.759, p = 0.001; HR for ACRG = 5.144, p < 0.001).

Conclusion

The combination of ACRG molecular subtyping and PD‐L1 expression serves as an effective predictor of GC prognosis, facilitating tailored clinical decision‐making. The ACRG‐PD‐L1 classification system offers a practical, cost‐effective approach for routine clinical application, providing critical insight into GC heterogeneity. Further multicenter studies are needed to validate these findings and explore the impact of ACRG subtypes on therapy responses, particularly in immunotherapy settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsB7-H1 AntigenBiomarkers, TumorHumansMaleFemalePrognosisMiddle AgedRetrospective StudiesImmunohistochemistryAgedMicrosatellite InstabilityAdultEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

ACRG typingMSIMSSPD‐L1gastric cancerprognosis

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Graduate School, Hebei Medical University, Shijiazhuang, China.
  • Department of Emergency, Pingxiang General Hospital, Xingtai, China.
  • Department of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China.

ORCID-Profile: Fang Li, Huiyan Deng

Förderung

  • Medical Science Research Project of Hebei

Zitieren

APA

Li, F., Deng, H., Hu, Z., Chen, Z., Zhang, H., He, J., Wang, X., & Liu, Y. (2025). Immunohistochemical‐Based Molecular Typing of ACRG Combined With Immune‐Associated PD ‐ L1 Expression Can Predict the Prognosis of Gastric Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.70863

Vancouver

Li F, Deng H, Hu Z, Chen Z, Zhang H, He J, et al. Immunohistochemical‐Based Molecular Typing of ACRG Combined With Immune‐Associated PD ‐ L1 Expression Can Predict the Prognosis of Gastric Cancer. Cancer Medicine. 2025. doi:10.1002/cam4.70863

BibTeX
@article{Li2025,
  author = {Li, Fang and Deng, Huiyan and Hu, Zeqing and Chen, Zihao and Zhang, Huirui and He, Jiankun and Wang, Xiaoxiao and Liu, Yueping},
  title = {Immunohistochemical‐Based Molecular Typing of ACRG Combined With Immune‐Associated PD ‐ L1 Expression Can Predict the Prognosis of Gastric Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70863}
}
Kostenlos starten →